Advanced Milignant Gliomas的临床试验
总计11405个结果
-
The First People's Hospital of Changzhou尚未招聘Cytokine-Induced Killer Cells | Advanced Milignant Gliomas
-
Galderma R&D完全的确定皮肤对 Cetaphil Daily Advance 超保湿乳液的敏感性
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的胶质母细胞瘤 | 胶质肉瘤 | 恶性胶质瘤美国
-
University of Colorado, DenverAstraZeneca完全的
-
Peking Union Medical College HospitalBeijing Tiantan Hospital; Tianjin Medical University General Hospital未知
-
London Health Sciences CentreUniversity of Western Ontario, Canada; London Regional Cancer Program, Canada终止
-
Rigshospitalet, DenmarkOdense University Hospital; Aalborg University Hospital完全的
-
National Cancer Institute (NCI)招聘中
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
University of California, San Francisco完全的
-
National Cancer Institute (NCI)完全的复发性高级别胶质瘤 | 恶性胶质瘤 | Progressive Low-Grade Gliomas美国
-
Advanced Bionics完全的重度至重度听力损失 | 在 Advanced Bionics HiResolution™ 仿生耳系统的成人用户中美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Tactical Therapeutics, Inc.主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)主动,不招人胶质母细胞瘤 | 世界卫生组织 3 级神经胶质瘤 | 晚期恶性实体瘤 | 复发性恶性实体瘤 | 复发性胶质瘤 | 复发性胆管癌 | 世界卫生组织 2 级神经胶质瘤美国
-
The First People's Hospital of Changzhou尚未招聘Cytokine-Induced Killer Cells | Milignant Gliomas
-
National Cancer Institute (NCI)尚未招聘晚期恶性实体瘤 | 转移性恶性实体瘤
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Advanced Integrative Medical Science Institute招聘中